Search

DECIPHER BIOSCIENCES ACHIEVES MAJOR MEDICARE MILESTONE FOR DECIPHER PROSTATE GENOMIC TESTS

First Precision Oncology Company to Receive Medicare Coverage for Both Favorable and Unfavorable Intermediate Risk Prostate Cancer SAN...

A NEW WAY TO CONTROL MICROBIAL METABOLISM

Microbes can be engineered to produce a variety of useful compounds, including plastics, biofuels, and pharmaceuticals. However, in...

 
 
 
Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy

NEUROCRINE INKS $50M XENON PHARMA DEAL TO EXPAND INTO EPILEPSY

Neurocrine Biosciences is paying $30 million cash and taking a $20 million equity stake in Xenon Pharmaceuticals to license a clinical-stage...

NEUROCRINE BIO TAKES AIM AT EPILEPSY WITH $50 MILLION ACQUISITON

Collaboration with Xenon Pharmaceuticals seeks to commercialize treatment for the disease...

 
 
 

EVOFEM BIOSCIENCES REPORTS POSITIVE TOP-LINE RESULTS FROM PHASE 2B STUDY OF AMPHORA® FOR PREVENTION OF CHLAMYDIA AND GONORRHEA IN WOMEN

AMPREVENCE Study Met Primary and Secondary Endpoints - a 50% Relative Risk Reduction in Chlamydia Infection and a 78% Relative Risk...

RESEARCHERS FINALLY GRASP THE WORK WEEK OF ENZYMES

Scientists have found a novel way of monitoring individual enzymes as they chomp through fat. The method offers far greater insight...

 
 
 
FDA amps up Big Pharma protection racket by attacking the CBD industry, claiming natural cannabinoids are "unapproved drugs" even though hemp existed for thousands of years before the FDA was even founded in 1906

FDA AMPS UP BIG PHARMA PROTECTION RACKET BY ATTACKING THE CBD INDUSTRY, CLAIMING NATURAL CANNABINOIDS ARE "UNAPPROVED DRUGS" EVEN THOUGH HEMP EXISTED FOR THOUSANDS OF YEARS BEFORE THE FDA WAS EVEN FOUNDED IN 1906

Hundreds of thousands of people living in the United States die every single year from taking pharmaceutical drugs that the U.S. Food...

Report: Prosecutors use Controlled Substances Act to investigate opioid makers, distributors

REPORT: PROSECUTORS USE CONTROLLED SUBSTANCES ACT TO INVESTIGATE OPIOID MAKERS, DISTRIBUTORS

The Wall Street Journal reported that at least six companies' disclosures that they had received subpoenas were related to the investigation,...

 
 
 
A Minimally Invasive Hollow Microneedle with a Cladding Structure: Ultra-Thin but Strong, Batch Manufacturable

A MINIMALLY INVASIVE HOLLOW MICRONEEDLE WITH A CLADDING STRUCTURE: ULTRA-THIN BUT STRONG, BATCH MANUFACTURABLE

Jiaming Chen , Ping Cheng , Yunna Sun , Yipin Wang , Xiaojing Zhang , Guifu Ding Institution: National Key Laboratory of Micro/Nano...

Pharma stocks plunged after federal prosecutors launched a criminal probe into their role in fueling the opioid crisis

PHARMA STOCKS PLUNGED AFTER FEDERAL PROSECUTORS LAUNCHED A CRIMINAL PROBE INTO THEIR ROLE IN FUELING THE OPIOID CRISIS

Drug stocks plunged on Tuesday after the Wall Street Journal reported that federal prosecutors have launched a criminal probe into...

 
 
 

TERSO SOLUTIONS ANNOUNCES 2020 TRADESHOW PARTICIPATION

MADISON, Wis., Nov. 26, 2019 /PRNewswire/ - Terso Solutions, the leading provider of automated inventory management solutions for tracking...

SENIOR MANAGER FACILITIES - DEXCOM - SAN DIEGO, CA

A minimum 3 years of experience managing commercial manufacturing facilities under GMP regulatory compliance in the pharmaceutical,...

 
 
 

ENCOURAGING EARLY RESULTS FROM FIRST HUMAN CRISPR GENE THERAPY TRIALS

Posted on: 25 November 2019, Promising preliminary data from one of the first human trials testing the safety and efficacy of a CRISPR...

 
 
 

AKCEA AND IONIS ANNOUNCE INITIATION OF NEURO-TTRANSFORM PHASE 3 CLINICAL TRIAL FOR AKCEA-TTR-LRX IN PATIENTS WITH POLYNEUROPATHY DRIVEN BY HEREDITARY TTR AMYLOIDOSIS

BOSTON and CARLSBAD, Calif., Nov. 25, 2019 - Akcea Therapeutics, Inc. , a majority-owned affiliate of Ionis Pharmaceuticals, Inc.,...

DELMAR PHARMACEUTICALS PRESENTS POSITIVE INTERIM DATA OF VAL-083 DEMONSTRATING FAVORABLE OUTCOMES IN BOTH RECURRENT AND NEWLY-DIAGNOSED GBM

Newly-Diagnosed Patients Showing Promising Progression-Free Survival Compared to TMZ Historical DataRecurrent Patients Showing Promising...

 
 
 

FERRING, BLACKSTONE SPIN OUT GENE THERAPY WITH $570M IN FUNDING

Ferring Pharmaceuticals has spun out its late-phase gene therapy nadofaragene firadenovec with the support of Blackstone Life Sciences....

SENIOR MANAGER, CLINICAL DATA MANAGEMENT - XENCOR - SAN DIEGO, CA

Pharmaceutical, Biotechnology or relevant clinical CRO experience, including 6+ years in clinical data management.From Xencor - Sat,...

 
 
 

IRISYS: PHARMACEUTICAL QA SPECIALIST

IRISYS: Pharmaceutical Quality Assurance Specialist needed at our company in San Diego, CA. San Diego, CA ...

Reata Rakes In $505M to Advance Development of Two Rare Disease Drugs

REATA RAKES IN $505M TO ADVANCE DEVELOPMENT OF TWO RARE DISEASE DRUGS

Reata Pharmaceuticals on Tuesday closed a stock sale, raising $505.1 million to advance the company's two lead drug candidates to regulatory...